ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,235, issued on Sept. 15.
"AAV5-based vaccine against SARS-CoV-2" was invented by Alexander Vladimirovich Prokofyev (Saint Petersburg, Russia), Pavel Mikhailovich Gershovich (Saint Petersburg, Russia), Anna Nikolaevna Strelkova (g. Yaransk, Russia), Natalia Aleksandrovna Spirina (Saint Petersburg, Russia), Diana Aleksandrovna Kondinskaia (Saint Petersburg, Russia), Pavel Andreevich Iakovlev (Saint Petersburg, Russia) and Dmitry Valentinovich Morozov (Saint Petersburg, Russia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to the fields of biotechnology, immunology, virology, genetics, and molecular biology. More specif...